• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The influence of medroxyprogesterone acetate (MPA) on hormone parameters in prostatic carcinoma patients.

作者信息

Flamm J, Spona J

机构信息

Department of Urology, Wilhelminenspital Vienna, Austria.

出版信息

Int Urol Nephrol. 1988;20(2):131-7. doi: 10.1007/BF02550662.

DOI:10.1007/BF02550662
PMID:2968326
Abstract

In ten patients suffering from previously untreated, advanced, non-metastatic prostatic carcinoma, the effect of MPA on the hormonal parameters of testosterone and luteinizing hormone (LH) was examined. The dosage of MPA amounted to 500 mg i.m. daily for a week. Thereafter 1000 mg i.m. every four weeks were applied. Full castration could be achieved in all patients, and this effect could be kept up during the time of observation. The tolerance was good, there were no side effects.

摘要

相似文献

1
The influence of medroxyprogesterone acetate (MPA) on hormone parameters in prostatic carcinoma patients.
Int Urol Nephrol. 1988;20(2):131-7. doi: 10.1007/BF02550662.
2
[High-dosage medroxyprogesterone acetate treatment in advanced prostatic cancer].
Wien Klin Wochenschr. 1987 Oct 9;99(19):682-6.
3
Hormonal effects of high dose medroxyprogesterone acetate treatment in males with renal or prostatic adenocarcinoma.
Scand J Urol Nephrol. 1988;22(1):15-8. doi: 10.1080/00365599.1988.11690377.
4
Flushing. Long-term side effect of orchiectomy in treatment of prostatic carcinoma.潮热。睾丸切除术治疗前列腺癌的长期副作用。
Urology. 1989 Mar;33(3):175-8. doi: 10.1016/0090-4295(89)90385-3.
5
The effects of diethylstilbestrol and medroxyprogesterone acetate on kinetics and production of testosterone and dihydrotestosterone in patients with prostatic carcinoma.己烯雌酚和醋酸甲羟孕酮对前列腺癌患者睾酮和双氢睾酮动力学及生成的影响。
J Clin Endocrinol Metab. 1976 Dec;43(6):1226-33. doi: 10.1210/jcem-43-6-1226.
6
Reversible inhibition of sperm production and gonadotrophin secretion in men following combined oral medroxyprogesterone acetate and percutaneous testosterone treatment.联合口服醋酸甲羟孕酮和经皮睾酮治疗后男性精子生成和促性腺激素分泌的可逆性抑制
Acta Endocrinol (Copenh). 1983 Apr;102(4):625-32. doi: 10.1530/acta.0.1020625.
7
Results of a Dutch trial with the LHRH agonist buserelin in patients with metastatic prostatic cancer and results of EORTC studies in prostatic cancer.
Am J Clin Oncol. 1988;11 Suppl 1:S33-5.
8
Medroxyprogesterone acetate (MPA) treatment of sexual acting out in men suffering from dementia.醋酸甲羟孕酮（MPA）治疗患有痴呆症男性的性冲动行为。
J Clin Psychiatry. 1987 Sep;48(9):368-70.
9
Effect of high-dose medroxyprogesterone acetate on plasma hormone levels and pain relief in patients with advanced prostatic cancer.大剂量醋酸甲羟孕酮对晚期前列腺癌患者血浆激素水平及疼痛缓解的影响。
Br J Urol. 1990 Mar;65(3):278-81. doi: 10.1111/j.1464-410x.1990.tb14727.x.
10
High-dose medroxyprogesterone in the treatment of advanced therapy-resistant prostatic carcinoma.大剂量甲羟孕酮治疗晚期难治性前列腺癌。
Eur Urol. 1985;11(1):9-10. doi: 10.1159/000472440.

本文引用的文献

1
Endocrine therapy in carcinoma of the prostate gland: 10-year survival studies.前列腺癌的内分泌治疗：10年生存研究。
J Urol. 1960 Apr;83:471-84. doi: 10.1016/S0022-5347(17)65741-0.
2
Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941.前列腺癌研究：I. 去势、雌激素及雄激素注射对前列腺转移性癌血清磷酸酶的影响。1941年。
J Urol. 2002 Jul;168(1):9-12. doi: 10.1016/s0022-5347(05)64820-3.
3
Prostate cancer. Endocrine and cytotoxic therapy.
前列腺癌。内分泌治疗和细胞毒性治疗。
Recent Results Cancer Res. 1981;78:154-72. doi: 10.1007/978-3-642-81621-5_11.
4
Effect of progestational agents on carcinoma of the prostate.孕激素制剂对前列腺癌的影响。
Cancer Chemother Rep. 1967 Feb;51(1):41-6.
5
Effect of oestrogen on liver function of prostatic cancer patients.
Br Med J. 1969 Oct 25;4(5677):204-5. doi: 10.1136/bmj.4.5677.204.
6
Effect of hormonal therapy on plasma testosterone levels in prostatic carcinoma.激素疗法对前列腺癌患者血浆睾酮水平的影响。
Br Med J. 1971 Nov 13;4(5784):391-4. doi: 10.1136/bmj.4.5784.391.
7
The effect of orchiectomy and various doses of stilbestrol on plasma testosterone levels in patients with carcinoma of the prostate.睾丸切除术及不同剂量己烯雌酚对前列腺癌患者血浆睾酮水平的影响。
Invest Urol. 1972 Mar;9(5):423-5.
8
Testosterone turnover in cancer of the prostate: suppression by gestagens in vitro.
Invest Urol. 1974 Sep;12(2):157-61.
9
[Intra- and extracellular electrolyte concentration of estrogen therapy on patients with carcinoma of the prostate (author's transl)].
Urologe A. 1973 Sep;12(5):274-7.
10
Plasma testosterone: an accurate monitor of hormone treatment in prostatic cancer.血浆睾酮：前列腺癌激素治疗的精确监测指标。
Br J Urol. 1973 Dec;45(6):668-77. doi: 10.1111/j.1464-410x.1973.tb12238.x.